Bridgeway Capital Management’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$502K Hold
61,800
0.01% 777
2025
Q1
$435K Sell
61,800
-17,000
-22% -$120K 0.01% 768
2024
Q4
$585K Buy
78,800
+1,900
+2% +$14.1K 0.01% 778
2024
Q3
$379K Hold
76,900
0.01% 925
2024
Q2
$394K Hold
76,900
0.01% 916
2024
Q1
$408K Buy
+76,900
New +$408K 0.01% 976
2023
Q1
Sell
-55,000
Closed -$356K 1407
2022
Q4
$356K Hold
55,000
0.01% 956
2022
Q3
$489K Sell
55,000
-25,000
-31% -$222K 0.01% 900
2022
Q2
$798K Hold
80,000
0.02% 778
2022
Q1
$926K Sell
80,000
-25,000
-24% -$289K 0.02% 803
2021
Q4
$1.17M Buy
+105,000
New +$1.17M 0.02% 755
2020
Q4
Sell
-15,000
Closed -$146K 1340
2020
Q3
$146K Hold
15,000
﹤0.01% 1222
2020
Q2
$119K Buy
+15,000
New +$119K ﹤0.01% 1220
2019
Q1
Sell
-16,000
Closed -$189K 1370
2018
Q4
$189K Sell
16,000
-9,900
-38% -$117K ﹤0.01% 1226
2018
Q3
$373K Hold
25,900
﹤0.01% 1208
2018
Q2
$386K Hold
25,900
﹤0.01% 1200
2018
Q1
$338K Hold
25,900
﹤0.01% 1178
2017
Q4
$326K Hold
25,900
﹤0.01% 1199
2017
Q3
$335K Buy
+25,900
New +$335K ﹤0.01% 1180
2016
Q2
Sell
-44,200
Closed -$464K 1462
2016
Q1
$464K Sell
44,200
-25,000
-36% -$262K 0.01% 1090
2015
Q4
$819K Hold
69,200
0.02% 845
2015
Q3
$808K Hold
69,200
0.02% 824
2015
Q2
$999K Sell
69,200
-20,000
-22% -$289K 0.02% 789
2015
Q1
$1.24M Sell
89,200
-16,500
-16% -$230K 0.03% 701
2014
Q4
$1.46M Hold
105,700
0.03% 636
2014
Q3
$1.3M Sell
105,700
-130,900
-55% -$1.6M 0.03% 649
2014
Q2
$2.96M Buy
236,600
+130,900
+124% +$1.63M 0.08% 370
2014
Q1
$1.18M Sell
105,700
-11,900
-10% -$133K 0.03% 691
2013
Q4
$1.43M Sell
117,600
-74,100
-39% -$898K 0.04% 609
2013
Q3
$2.34M Sell
191,700
-164,500
-46% -$2.01M 0.08% 351
2013
Q2
$4.71M Buy
+356,200
New +$4.71M 0.19% 92